Abstract Number: 1933 • 2012 ACR/ARHP Annual Meeting
Incidence and Early Detection of Retinal Toxicity in Patients Treated with Chloroquine and Hydroxichloroquine in Rheumatology Practice
Background/Purpose: The antimalarial drugs are considered safe and well tolerated, with low risk of side effects. Hydroxychloroquine is considered safer but less effective than chloroquine,…Abstract Number: 1934 • 2012 ACR/ARHP Annual Meeting
Improvement in Cryoglobulin Detection Employing a Temperature Controlled Sample Transporter
Background/Purpose: Optimal conditions for detecting serum cryoglobulins in patients with suspected vasculitis requires drawn blood samples remain at 37 degree F or higher temperature until…Abstract Number: 1935 • 2012 ACR/ARHP Annual Meeting
Longitudinal Peripheral Blood Lymphocyte Subsets Correlate with Decreased Disease Activity in Juvenile Dermatomyositis
Background/Purpose: Perturbations in peripheral blood lymphocyte (PBL) subsets in juvenile dermatomyositis (JDM) are variably and inconsistently reported in active and inactive disease. Decreased PBL CD8+…Abstract Number: 1936 • 2012 ACR/ARHP Annual Meeting
The Human Leukocyte Antigen DRB1*13:02-DQB1*06:04-DPB1*04:01 Haplotype Is Closely Associated with Dermatomyositis Patients with Anti-CADM-140 (Melanoma Differentiation-Associated Protein 5: MDA5) Antibody
Background/Purpose: Recent studies have revealed that anti-CADM-140 (MDA5/IFIH1)-antibody positive dermatomyositis (DM) patients frequently develop acute or subacute progressive interstitial pneumonia (A/SIP) with poor prognosis. However,…Abstract Number: 1937 • 2012 ACR/ARHP Annual Meeting
HLA-DRB1*0101/*0405 Is Associated with Susceptibility to Anti-MDA5 Antibody-Positive Dermatomyositis in the Japanese Population
Background/Purpose: The complication of interstitial lung disease (ILD) is associated with the anti-aminoacyl tRNA synthetase antibody (ARS ab) or the anti-melanoma differentiation-associated gene 5 antibody…Abstract Number: 1938 • 2012 ACR/ARHP Annual Meeting
A New Enzyme-Linked Immunosorbent Assay System for Detecting Autoantibodies to Aminoacyl-tRNA Synthetases: Clinical Usefulness in Myositis and Interstitial Pneumonia
Background/Purpose: Autoantibodies to aminoacyl-tRNA synthetases (ARS) are the most frequent myositis-specific antibodies and they are useful in the diagnosis and management of polymyositis (PM)/ dermatomyositis…Abstract Number: 1899 • 2012 ACR/ARHP Annual Meeting
Factors Contributing to Non-Publication of Abstracts Presented At the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting
Background/Purpose: The American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Scientific Meeting (ASM) provides a premier forum for the rapid dissemination of novel…Abstract Number: 1900 • 2012 ACR/ARHP Annual Meeting
Mormed Project: A New 21st Century Web Platform for Multilingual Communication in systemic Lupus Erythematosus and Antiphospholipid Syndrome
Background/Purpose: The internet is used nowadays as the preferred repository where people search for, access and publish information on any topic. However, language barriers prevent…Abstract Number: 1901 • 2012 ACR/ARHP Annual Meeting
Chronic Gout. Improvement According to Outcome Meaures in Rheumatology Domains in Daily Clinical Practice
Background/Purpose: OMERACT has proposed domains to evaluate the effect of treatment in patients with acute and chronic gout. Their frequency, time to improve and percentage…Abstract Number: 1902 • 2012 ACR/ARHP Annual Meeting
What Factors Are Associated with Target Serum Urate Concentrations in Patients with Gout?
Background/Purpose: Long term serum urate (SU) lowering to a target ofAbstract Number: 1903 • 2012 ACR/ARHP Annual Meeting
Oxidation of Urate to Allantoin by Myeloperoxidase in Gout
Background/Purpose : Hyperuricaemia is critical for the development of gout and may play a pivotal role in the pathophysiology of hypertension, metabolic syndrome, and cardiovascular…Abstract Number: 1904 • 2012 ACR/ARHP Annual Meeting
Patterns of Gout Treatment and Related Outcomes in US Community Rheumatology Practices: the Relation Between Gout Flares, Time in Treatment, Serum Uric Acid Level and Urate Lowering Therapy
Background/Purpose: Study patterns of gout treatment and related outcomes in US community rheumatology practices, specifically the relation between likelihood and severity of gout flares, time…Abstract Number: 1905 • 2012 ACR/ARHP Annual Meeting
Increase of Thyroid Stimulating Hormone in Patients On Febuxostat Treatment
Background/Purpose: to evaluate whether TSH increases during febuxostat treatment and factors that could be implicated.Methods: before starting febuxostat, patients had analysis at baseline and month…Abstract Number: 1906 • 2012 ACR/ARHP Annual Meeting
Changes in Gout patient´s Clinical Profile in the Last Two Decades
Background/Purpose: to assess whether changes in the clinical profile of gout are observed in a large cohort of gout patients over the last 20 years.…Abstract Number: 1907 • 2012 ACR/ARHP Annual Meeting
Pharmacological Management of Gout in Italy in the Years 2005-2009: A Nationwide, Population-Based Study
Background/Purpose: Despite the increasing interest on gout, only few nationwide drug utilization studies have been conducted on this topic. The aim of this study…